Union City, CA, United States of America

Ziyang Zhong


 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2001-2013

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **The Innovations of Inventor Ziyang Zhong**

Introduction

Ziyang Zhong is a prominent inventor based in Union City, California. With a remarkable portfolio of 10 patents, he has made significant contributions to the field of therapeutic formulations and polypeptide innovations.

Latest Patents

Among his latest patents, Ziyang Zhong has developed therapeutic formulations of desoxyepothilones, which are stable both before and after dilution into aqueous media. Additionally, his work on GSK3 polypeptides includes truncated variants capable of crystallization, specifically GSK3α and GSK3β. These advancements allow for the identification and optimization of GSK3 inhibitors, facilitating methods for treating diseases associated with GSK3 activity, such as Alzheimer's disease, type 2 diabetes, and inflammation.

Career Highlights

Zhong’s career includes significant roles at notable companies such as Chiron Corporation and Scios Inc. His tenure at these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical and therapeutic applications.

Collaborations

Throughout his career, Ziyang Zhong has collaborated with esteemed colleagues including Stephen David Harrison and John Andrew Hall. These partnerships have likely enriched his research and development endeavors, fostering innovation through collective expertise.

Conclusion

Ziyang Zhong exemplifies the spirit of innovation through his extensive work and inventions. His patents not only demonstrate his expertise in biotechnology but also hold promise for significant advancements in the treatment of various medical conditions. As he continues to develop new ideas and applications, Zhong is poised to remain a key figure in the realm of medical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…